Thiocarlide

Chemical compound
  • J04AD02 (WHO)
Identifiers
  • 1,3-bis[4-(3-methylbutoxy)phenyl]thiourea
CAS Number
  • 910-86-1 ☒N
PubChem CID
  • 3001386
ChemSpider
  • 2272774 checkY
UNII
  • 43M23X81Y2
KEGG
  • D07246
ChEMBL
  • ChEMBL214920 checkY
CompTox Dashboard (EPA)
  • DTXSID70238358 Edit this at Wikidata
ECHA InfoCard100.011.824 Edit this at WikidataChemical and physical dataFormulaC23H32N2O2SMolar mass400.58 g·mol−13D model (JSmol)
  • Interactive image
  • S=C(Nc1ccc(OCCC(C)C)cc1)Nc2ccc(OCCC(C)C)cc2
InChI
  • InChI=1S/C23H32N2O2S/c1-17(2)13-15-26-21-9-5-19(6-10-21)24-23(28)25-20-7-11-22(12-8-20)27-16-14-18(3)4/h5-12,17-18H,13-16H2,1-4H3,(H2,24,25,28) checkY
  • Key:BWBONKHPVHMQHE-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Thiocarlide (or tiocarlide or isoxyl) is a thiourea drug used in the treatment of tuberculosis, inhibiting synthesis of oleic acid and tuberculostearic acid.[1]

Thiocarlide has considerable antimycobacterial activity in vitro and is effective against multi-drug resistant strains of Mycobacterium tuberculosis.[2] Isoxyl inhibits M. bovis with six hours of exposure, which is similar to isoniazid and ethionamide, two other prominent anti-TB drugs. Unlike these two drugs, however, isoxyl also partially inhibits the synthesis of fatty acids.[citation needed]

Thiocarlide was developed by a Belgian company, Continental Pharma S.A. Belgo-Canadienne in Brussels, Belgium. The head researcher was Professor N. P. Buu-Hoi, head of Continental Pharma's Research Division.[citation needed]

References

  1. ^ Phetsuksiri B, Jackson M, Scherman H, et al. (December 2003). "Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis". J. Biol. Chem. 278 (52): 53123–30. doi:10.1074/jbc.M311209200. PMC 4747054. PMID 14559907.
  2. ^ Phetsuksiri B, Baulard AR, Cooper AM, et al. (May 1999). "Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis". Antimicrob. Agents Chemother. 43 (5): 1042–51. doi:10.1128/AAC.43.5.1042. PMC 89109. PMID 10223912.
  • v
  • t
  • e
Nucleic acid inhibitor
Rifamycins/
RNA polymerase inhibitor
Antifolates/DSI
ASA
Topoisomerase inhibitors/
quinolones
Protein synthesis inhibitor
Aminoglycosides
Oxazolidone
Polypeptide antibiotics
Cell envelope antibiotic
Peptidoglycan layer
Arabinogalactan layer
Mycolic acid layer
Other/unknownCombinations
Stub icon

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e